Figures
There are errors in the Correction published on April 8, 2021. The corrected figures are incorrect. The correct figures are:
Prevalence rates of anti-HAV IgG (A), HBsAg (B), anti-HBc IgG (C), anti-HBs ≥10 mUI/ml (D) and anti-HEV IgG (E) by age groups in different regions of Peru.
Prevalence rates of anti-HAV IgG (A), HBsAg (B), anti-HBc IgG (C), anti-HBs ≥10 mUI/ml (D) and anti-HEV IgG (E) by age groups in urban and rural areas of Peru.
Prevalence of HBsAg and hepatitis Delta before (A) [19] and after the implementation of the hepatitis B vaccination program in Peru (B).
The publisher apologizes for the errors.
References
- 1. Cabezas C, Trujillo O, Gonzales-Vivanco Á, Benites Villafane CM, Balbuena J, Borda-Olivas AO, et al. (2020) Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study. PLoS ONE 15(6): e0234273. https://doi.org/10.1371/journal.pone.0234273 pmid:32542052
- 2. The PLOS ONE Staff (2021) Correction: Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study. PLoS ONE 16(4): e0250185. https://doi.org/10.1371/journal.pone.0250185 pmid:33831111
Citation: The PLOS ONE Staff (2021) Correction: Correction: Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study. PLoS ONE 16(5): e0251539. https://doi.org/10.1371/journal.pone.0251539
Published: May 6, 2021
Copyright: © 2021 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.